Discovery on new form ETV6-related thrombocytopenia presented at EHA Annual Congress

NewsGuard 100/100 Score

We recently discovered a new form of an inherited deficiency of platelets (inherited thrombocytopenia-IT), which is caused by mutations in the ETV6-gene. The name we gave to this disorder is ETV6-related thrombocytopenia (ETV6-RT). In our case series it affects about 5% of patients with known IT.

ETV6-RT is transmitted by one parents and differs from most of the known ITs because the bleeding tendency is mild or absent and there are no morphological or functional abnormalities (such as very large platelets) that can suggest the diagnosis. In the majority of our patients, the evidence of the thrombocytopenia was incidental. That’s the real problem of ETV6-RT! This new form, indeed, is more dangerous than it seems: this condition puts patients at risk of developing hematological malignancies (blood cancers), in particular childhood B-cell acute lymphoblastic leukemia (ALL).

Since ETV6-RT is one of the few forms of IT without large platelets, we recommend a genetic screening for ETV6 mutations in all patients with IT and normal sized platelets. It is important to pay attention to the "dangerous hidden risk" of developing blood cancer (in order to define prognosis and plan a personalized follow-up regimen), than to bleeding complications, which are rare and usually do not affect the quality of life.

Presenter: Dr Federica Melazzini
Affiliation: IRCCS Policlinico San Matteo Foundation, University of Pavia, Italy
Topic: ETV6-RELATED THROMBOCYTOPENIA (ETV6-RT): CLINICAL AND PATHOGENETIC CHARACTERIZATION OF AN INHERITED THROMBOCYTOPENIA (IT) PREDISPOSING TO CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)

Abstract S148 will be presented by Federica Malazzini on Friday, June 10, 16:25 - 16:35 in Hall A1.

Source: http://www.ehaweb.org/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New platform can deliver gene therapy precisely to specific areas of the brain